2016
DOI: 10.1016/j.bbr.2015.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological characterization of intraplantar Complete Freund’s Adjuvant-induced burrowing deficits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
31
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 29 publications
(35 citation statements)
references
References 41 publications
3
31
1
Order By: Relevance
“… 17 , 53 First, it should be demonstrated to what extent clinically efficacious drugs reverse suppression of burrowing. In the CFA model, ibuprofen has been shown to reverse suppressed burrowing, whereas gabapentin, which has a large body of evidence supporting efficacy in neuropathic, but not inflammatory, pain, is appropriately inefficacious, 2 , 20 , 62 suggesting good pharmacologic sensitivity of suppressed burrowing. Second, compounds such as neurokinin 1 antagonists and cannabinoid 2 receptor agonists that have been shown to be efficacious in animal pain models measuring evoked endpoints but have failed in clinical trials 48 , 65 , 75 should be tested to assess the degree of pain specificity of burrowing.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 17 , 53 First, it should be demonstrated to what extent clinically efficacious drugs reverse suppression of burrowing. In the CFA model, ibuprofen has been shown to reverse suppressed burrowing, whereas gabapentin, which has a large body of evidence supporting efficacy in neuropathic, but not inflammatory, pain, is appropriately inefficacious, 2 , 20 , 62 suggesting good pharmacologic sensitivity of suppressed burrowing. Second, compounds such as neurokinin 1 antagonists and cannabinoid 2 receptor agonists that have been shown to be efficacious in animal pain models measuring evoked endpoints but have failed in clinical trials 48 , 65 , 75 should be tested to assess the degree of pain specificity of burrowing.…”
Section: Discussionmentioning
confidence: 99%
“… 45 Although burrowing is a relatively novel pain outcome measure, a few studies have reported decreased burrowing in rat models of inflammatory and neuropathic pain; importantly, burrowing deficits were reversed by known analgesics, suggesting a degree of predictive validity for this outcome measure. 2 , 9 , 20 , 35 , 61 , 62 …”
Section: Introductionmentioning
confidence: 99%
“…As burrowing activity decreases in many conditions that are likely accompanied by negative affective states, the behavior has been subsequently used in mice and rats to assess the impact and refinement of housing and experimental conditions (see Figure 1). While burrowing activity in rats is mainly used to assess different pain types or analgesic efficacy (e.g., [67][68][69]), the use of this test in mice is more heterogeneous. Burrowing behavior is known to be reduced due to post-surgical pain (e.g., [70]), experimental procedures like anesthesia [71], or experimental housing conditions like grid housing [72].…”
Section: Burrowingmentioning
confidence: 99%
“…For example, the inclination of mice to build nests (from pieces of nesting material arranged in a standardized way in test cages) and the time taken to do so are decreased under conditions of inflammatory or visceral pain (Negus et al, ). Rats and mice will also burrow less (remove quantifiable amounts of material from an artificial burrow) when experiencing inflammatory or postsurgical pain (Jirkof et al, ; Andrews et al, ; Gould et al, ). Although these tests can assign numerical values to ongoing pain magnitude and effects of analgesics, in the case of SCI (in which their use has been practically nonexistent), they cannot provide information on pain locus (e.g., at‐ or below‐level pain).…”
Section: Measuring Neuropathic Pain Following Sci: What Is Required Imentioning
confidence: 99%